Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
14.1M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
566K
-
Shares change
-
+67.9K
-
Total reported value, excl. options
-
$1.22M
-
Value change
-
+$147K
-
Number of buys
-
6
-
Number of sells
-
-2
-
Price
-
$2.16
Significant Holders of Indaptus Therapeutics, Inc. - Common Stock (INDP) as of Q3 2022
12 filings reported holding INDP - Indaptus Therapeutics, Inc. - Common Stock as of Q3 2022.
Indaptus Therapeutics, Inc. - Common Stock (INDP) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 566K shares
of 14.1M outstanding shares and own 4.01% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (250K shares), INVESTMENT HOUSE LLC (95.6K shares), STRATEGY ASSET MANAGERS LLC (55.3K shares), GEODE CAPITAL MANAGEMENT, LLC (50.6K shares), Stratos Wealth Partners, LTD. (26.8K shares), Vivaldi Capital Management LP (24K shares), RENAISSANCE TECHNOLOGIES LLC (19.7K shares), STATE STREET CORP (19.5K shares), NORTHERN TRUST CORP (12.9K shares), and CITADEL ADVISORS LLC (10.9K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.